SNPMiner Trials by Shray Alag


SNPMiner Trials: Clinical Trial Report


Report for Clinical Trial NCT00260897

Developed by Shray Alag, 2019.
SNP Clinical Trial Gene

Molecular Genetic Study of Avascular Necrosis of the Femoral Head-Revealing ANFH Pathogenesis Mechanism by Cell and Animal Models

Avascular necrosis of the femoral head (ANFH) is a debilitating disease that commonly leads to destruction of the hip joint in patients at middle age of life and often requires surgical intervention. Previously, we have identified the collagen type II, alpha 1 (COL2A1) gene as the ANFH disease gene. In this grant proposal, we will establish cell ine and animal models to understand the pathophysiology of ANFH, and extend our ongoing study for identifying genes responsible for non-familiar ANFH by looking into other interacting molecules of the pathway.

NCT00260897 Osteonecrosis
MeSH: Necrosis Osteonecrosis Femur Head Necrosis
HPO: Avascular necrosis Morbus Kienboeck



Purpose: Screening

Time Perspective: Cross-Sectional, Prospective

Defined Population


There is one SNP

SNPs


1 G1170S

In the Pedigree I, a 3665G >A mutation in exon 50 of the COL2A1 gene (Genbank accession number NM_001844) and the substitution resulted in a Gly1170Ser codon change (Genbank accession number NP_001835). --- Gly1170Ser ---



HPO Nodes


HPO:
Avascular necrosis
Genes 66
COL2A1 IL10 KRAS ORC1 SLC2A10 IL12A USP8 SH3PXD2B PTPN11 ATP7A ARSB UFSP2 COMP CLCN7 HLA-B USB1 ADAMTS2 TINF2 RTEL1 ERAP1 CTC1 IL12A-AS1 ACAN HPGD SLCO2A1 WNT5A INPP5K SCARB2 TLR4 TRPS1 ACTB DVL1 DVL3 GBA ELP1 PHF6 ACTG1 DKC1 CDH23 TRPV4 CCR1 UBAC2 C4A PARN NOP10 EXT1 EXT2 FGFR1 WRAP53 FAS HBB NHP2 TERC FZD2 TERT CREBBP KLRC4 EP300 MEFV IL23R SIL1 STAT4 CA2 SMAD3 COL1A1 COL1A2
Morbus Kienboeck